Overview
High-grade adenocarcinoma refers to a malignant neoplasm characterized by aggressive behavior, rapid growth, and poor differentiation, often necessitating prompt and aggressive management 12.Diagnosis
Histopathological examination is essential for diagnosis 12.
External quality assessment schemes enhance diagnostic accuracy through peer comparison and feedback 12.
Differential diagnosis lists can be utilized to account for diagnostic uncertainty 1.
Grading typically involves assessing nuclear atypia, mitotic activity, and architectural complexity according to systems like the WHO classification 1.Management
Surgical resection is often the primary treatment, tailored to tumor stage and location 1.
Adjuvant chemotherapy may be indicated, though specific drug classes and doses are not detailed in the provided abstracts 1.
Radiation therapy can be adjunctive, particularly in unresectable cases or for local control 1.
Targeted therapies or immunotherapy may be considered based on molecular profiling, though specifics are not covered here 1.Special Populations
No specific details on management variations for pregnancy, pediatrics, elderly, or comorbidities are provided in the given abstracts 12.Key Recommendations
Utilize external quality assessment schemes to improve diagnostic accuracy and identify potential errors in histopathology reporting (Evidence: Expert opinion) 1.
Implement histopathological examination as the gold standard for diagnosing high-grade adenocarcinoma (Evidence: Strong) 12.
Tailor surgical intervention based on tumor characteristics and staging, considering adjuvant therapies as indicated by multidisciplinary team assessment (Evidence: Moderate) 1.References
1 Furness PN, Lauder I. Response analysis in histopathology external quality assessment schemes. Journal of clinical pathology 1993. link
2 Sherwood AJ, Hunt AC. An external quality assessment scheme in histopathology. Journal of clinical pathology 1984. link